SCHEMBL15112811

SCHEMBL15112811

CC(C)CCSCC(O)COCC(O)CC(C)C

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15112808 0.85 GBA1 (0.31)
SCHEMBL16976008 0.78 KDM4E (0.42) L3MBTL1
SCHEMBL15112812 0.74 GBA1 (0.32)
SCHEMBL12064098 0.73 HSD17B10 (0.33)
SCHEMBL15112809 0.73 LMNA (0.31)
SCHEMBL20127155 0.73 HSD17B10 (0.32) L3MBTL1
SCHEMBL15112810 0.72 LMNA (0.34)
SCHEMBL11966892 0.69 USP2 (0.41) L3MBTL1
SCHEMBL15113124 0.68 KDM4E (0.36)
SCHEMBL12009823 0.68 HSD17B10 (0.41) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150297738-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2015-10-22 US disclosed
US-20140088298-A9 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2014-03-27 US disclosed
US-20140073602-A9 NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2014-03-13 US disclosed
US-20140073778-A9 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2014-03-13 US disclosed
US-20140073779-A9 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2014-03-13 US disclosed
US-20130217871-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-08-22 US disclosed
US-20130211060-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-08-15 US disclosed
US-20130184454-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-07-18 US disclosed
US-20130184237-A1 NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-07-18 US disclosed
US-20130184455-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088298-A9 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION HACL2, HASPIN, LIPA L3MBTL1 990/4885
US-20130211060-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION HACL2, HASPIN, LIPA L3MBTL1 990/4885
US-20130184237-A1 NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES NOS2, NOS3, NOS1 L3MBTL1 4825/4885
US-20140073602-A9 NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES NOS2, NOS3, NOS1 L3MBTL1 4825/4885
US-20150297738-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION HASPIN, HACL2, PCNA L3MBTL1 1206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.